Drug synthesis, including strontium salts, vitamin D and cyclopentadienol, in which the ratio of vitamin D to cyclopentadienol is between 1/40 and 1/800, is used to treat or prevent osteoporosis.
Pharmaceutical composition comprising as active ingredients a Strontium Salt and Vitamin D3 and a Cyclodextrin between excipients； useful for the treatment of Diseases of the bone orOsteoarthritis.Composición farmacéutica que comprende como principios activos una sal de estroncio y vitamina D3 y una ciclodextrina entre los excipientes； útil para el tratamiento de las enfermedades óseas o de la artrosis.
